Notes from the Floor: Bloom Burton & Co., Day 2

- May 3rd, 2018

The Bloom Burton & Co. Healthcare Investor Conference was held from May 2 to 3 in Toronto — here’s what happened on the second day of the show.

The Bloom Burton & Co. Healthcare Investor Conference just wrapped up in Toronto, and the Investing News Network (INN) was on site to provide coverage. 

Held from May 2 to May 3 at the Sheraton Center Hotel, the healthcare-focused event featured around 60 Canadian publicly traded and venture-backed private companies, along with promising pre-venture companies.

INN spent the second day of the show attending company and analyst presentations, as well as speaking with participants. Follow along below for a pictorial overview of day two of the conference, or click here to see what happened on day one.

  Life Science and Healthcare Investing report cover

Life Science and Healthcare Investing in 2021

The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2021 life science outlook report!

Day two began with a keynote presentation from Rajeev Shah of RA Capital Management. Shah spoke about how to build value for disruptive technologies in today’s world.

Company presentations took up the next chunk of the day. Execs from companies like Trillium Therapeutics (TSX:TRIL,NASDAQ:TRIL), LED Medical Diagnostics (TSXV:LMD) and Bellus Health (TSX:BLU) took the stage to share ideas.

Lunch time brought a well-attended panel moderated by Brian Bloom, Bloom Burton & Co.’s co-founder, chairman and CEO.

The talk was focused on investing in commercial-stage healthcare companies and featured: Ruoxi Chen of Warburg Pincus; Jeffrey Schwartz of Bain Capital Life Sciences; Thecia Sweeney of Birch Hill Equity Partners; Tadd Wessel of Petrichor Healthcare Capital Management; and Jason Wild of JW Asset Management. All were able to share insightful comments about the topic.

The afternoon brought more company presentations, and the INN team was able to take in a few. Presenters during the second half of the day included Aurinia Pharmaceuticals (TSX:AUP,NASDAQ:AUPH) and Immunovaccine (TSX:IMV).

Overall, attendees left the show feeling invigorated and satisfied with the two-day event. Stay tuned for INN’s audio interviews from the conference, and see you at the Bloom Burton & Co. conference in 2019!

Don’t forget to follow us @INN_LifeScience for real-time updates!

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

  Life Science and Healthcare Investing in 2020 report cover

An Overview for Investors

COVID-19 continues to impact world markets. Get INN’s overview of coronavirus investing.

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply